Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Ep. 208.5: Part Two, Lateral Flow Technologies of Today and Tomorrow - Paul Davis

Ep. 208.5: Part Two, Lateral Flow Technologies of Today and Tomorrow - Paul Davis

FromHalteres Presents


Ep. 208.5: Part Two, Lateral Flow Technologies of Today and Tomorrow - Paul Davis

FromHalteres Presents

ratings:
Length:
54 minutes
Released:
Sep 5, 2023
Format:
Podcast episode

Description

In Part Two of the Season 2 Finale of "Halteres Presents", Rich Thayer and Mickey Urdea continue their discussion with Paul Davis, dissecting the potential improvements to be made to today's lateral flow technologies, the possibilities (and realities) of what is yet to come with LFAs, and the best ways to build a team of inventors out of disparate personalities. Paul paints a detailed portrait of what "imagineering" can do to expand the scope and capabilities of lateral flow technologies, based on his trailblazing experiences in the field. Please enjoy Part Two of our interview with Paul Davis.

Paul Davis has worked in immunology for over 45 years and has founded or co-founded eight bioscience businesses since 2002, with Mologic being the most prominent. As Mologic’s chief scientific officer, Paul led the Centre for Advanced Rapid Diagnostics (CARD), funded by the Bill & Melinda Gates Foundation. Until 2002, he was as a senior scientist at Unilever Research leading applied immunology, and is one of the inventors of the lateral flow immunoassay.
Released:
Sep 5, 2023
Format:
Podcast episode

Titles in the series (21)

Halteres Presents is a brand-agnostic interview podcast designed to unbiasedly highlight the happenings within the diagnostics industry. In each episode, founding partner Mickey Urdea and managing partner Rich Thayer interview an expert who brings their own unique perspective to an industry topic. Halteres Associates is a leading bioscience consultancy with extensive, long-term, direct operating experience in a broad spectrum of areas of expertise, including the development and commercialization of diagnostics, medical devices, therapeutics, research reagents, and bioscience tools.